Replies to post #54033 on Biotech Values

[DewDiligence]

>…if it can be proven that the [Rhucin] product of Pharming is either of a higher quality (more pure), less prone to possible contamination, or otherwise safer in use, this could be a reason to declare Pharming’s product clinical superior and grant a subsequent license to Pharming.<

I hope they succeed because, as a rule, what’s good for Pharming is also good for GTC Biotherapeutics. Regards, Dew